# Abiraterone

## Zytiga 250mg

| TAH Drug Code      | [OZYT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OZYT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prostate cancer: Treatment of metastatic， castration-resistant prostate cancer (in combination with prednisone).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | [Metastatic castration-resistant prostate cancer] 1000 mg orally once daily with prednisone 5 mg orally twice daily.[Metastatic castration-sensitive prostate cancer] 1000 mg orally once daily with prednisone 5 mg orally once daily.Patients receiving ZYTIGA should also receive a gonadotropin-releasinghormone (GnRH) analog concurrently or should have had bilateral orchiectomy. ZYTIGA must be taken on an empty stomach with water at least 1 hour before or 2 hours after a meal. Do not crush or chew tablets.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Hypersensitivity. Pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Common: Contusion (13.3%)， Flushing (15-22.3%)， Hypercholesterolemia (Greater than 20%)， Hyperglycemia (56.6%)， Hypertriglyceridemia (62.5%)， Hypophosphatemia (23.8%)， Diarrhea (17.6-21.6%)， Vomiting (10% or higher)， Anemia (Greater than 20%)， Lymphocytopenia， All Grades (38.2%)， Alkaline phosphatase above reference range (Greater than 20%)， Joint swelling (29.5-30.3%)， Urinary tract infectious disease (7-11.5%)， Cough (6.5-17.3%)， Dyspnea (11.8%)， Fatigue (39.1%) Serious: Cardiac dysrhythmia (7.2%)， Cardiorespiratory arrest (0.5%)， Chest discomfort， Chest pain， Edema (25.1-26.7%)， Heart failure (2.3-2.6%)， Hypertension (8.5-37%)， Myocardial infarction， Sudden cardiac death， Torsades de pointes， Adrenal insufficiency (0.5%)， Hypoglycemia， Hypokalemia (17.2-28.3%)， Lymphocytopenia， Grade 3 or 4 (8.7%)， ALT/SGPT level raised (11.1-41.9%)， Aspartate aminotransferase serum level above reference range (16-37.3%)， Hepatotoxicity， Serum bilirubin above reference range (6.6%) |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/abiraterone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

